Healthcare -
Biotechnology - NASDAQ - US
$ 3.025
-8.79 %
$ 264 M
Market Cap
-2.92
P/E
TERN - REVENUE
Revenue TERN - Terns Pharmaceuticals, Inc.
0
LAST VALUE
0.00%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR